Pfizer
235 East 42nd Street
New York, NY 10017
United States
Tel: (212) 733-2323
Website: https://www.pfizer.com/
5519 articles about Pfizer
-
Pfizer Inc. Extends $3.6 Billion Tender Offer To Acquire King Pharmaceuticals®, Inc.
12/16/2010
-
Catalyst Biosciences, Inc. Receives $4 Million Milestone Payment from Pfizer Inc. for Progress in Lead Hemostasis Program
12/16/2010
-
Drug Research Gets New Asian Focus With Companies like Pfizer Inc., Johnson & Johnson and Bristol-Myers Squibb Company
12/15/2010
-
Pfizer Inc. Board of Directors Elects George A. Lorch Non-Executive Chairman
12/14/2010
-
Wikileaks' Cable Targets Pfizer Inc.
12/13/2010
-
Steve Yang, Pfizer Inc.'s Asia Head of R&D, Leaves for AstraZeneca PLC
12/13/2010
-
Pfizer Inc. Recalls Lung Drug Thelin, Ends Phase 3 Clinical Trials
12/13/2010
-
Pfizer Inc.'s Kindler to Get $9.6 Million in Severence, Bonus After Departure
12/10/2010
-
MorphoSys AG Signs Long-Term Alliance with Pfizer Inc. on Sloning Technology Platform
12/10/2010
-
Pfizer Inc., Novartis AG and AstraZeneca PLC Cancer Drugs Aromasin, Arimidex, and Femara Increase Heart Risks
12/9/2010
-
Pfizer Inc. Names Simmons Head of Emerging Markets
12/9/2010
-
Pfizer Inc.'s Investigational Compound Bosutinib Fails to Meet Primary Endpoint in Phase 3 Study For Chronic Myeloid Leukemia
12/7/2010
-
Pfizer Inc. Pays NYC $25M Penalty After Transferring HQ Jobs
12/7/2010
-
Pfizer Inc. CEO Leaves 'Extremely Demanding' Job; Ian Read to Replace Jeffrey B. Kindler
12/7/2010
-
Pfizer Inc. Plans Regulatory Submissions of Bosutinib in Chronic Myeloid Leukemia
12/6/2010
-
US Cable: Pfizer Inc. Sought Dirt on Nigerian official
12/2/2010
-
Icagen, Inc. and Pfizer Inc. Select Compound for Advancement in Nav1.7 Program
11/30/2010
-
Pfizer Inc. to Present Data from Its Hematology Portfolio at the 52nd Annual Meeting of the American Society of Hematology
11/29/2010
-
Pfizer Inc. and Protalix Biotherapeutics Announce Submission of taliglucerase alfa for European Marketing Authorization for the Treatment of Gaucher Disease
11/29/2010
-
Pfizer Inc. Extends Tender Offer to Acquire King Pharmaceuticals®, Inc.
11/22/2010